Not Prosecuting Free Oxygen Suppliers, Drug Controller Tells Delhi HC

New Delhi : The Drugs Control Department informed the Delhi High Court on Thursday that it has decided not to prosecute those who were involved in supplying free oxygen cylinders to COVID-19 patients in the Capital during the second wave of the pandemic.

A Bench of Justices Vipin Sanghi and Jasmeet Singh said the stand taken by the department was the “right approach”. Taking note of the submission, the court also decided to dispose of a petition seeking the lodging of an FIR on allegations that politicians were able to procure COVID medicines in huge quantities and distribute them even as patients were running from pillar to post to get them.

‘No wrongful intention’

Senior advocate Rahul Mehra, representing the Delhi government, said they have decided not to launch any prosecution against social organisations, individuals and gurdwaras which procured and distributed medical oxygen to COVID patients free of cost and without any wrongful intention.

Mr. Mehra said the pandemic is not yet over and if prosecution is launched in such cases, no good Samaritan would come forward in future to help the needy for fear of being punished.

In the previous hearing, the High Court had slammed the drug controller for initiating proceedings against AAP MLA Praveen Kumar for procuring and distributing oxygen cylinders during the second wave.

The court had said it would not permit prosecution of good Samaritans for helping society at a time when the state had failed to provide oxygen.

“If you initiate prosecution like this, you will have to pick up half the gurdwaras, temples, churches and all political parties as well. We won’t allow this,” the court had remarked, adding it was “unfortunate that a tragedy is being used for political capital”.

It, however, drew a distinction between the AAP MLA’s case and that of BJP MP from East Delhi, Gautam Gambhir, who had procured, stocked and distributed a large quantity of medicines to COVID-19 patients. The court remarked that Mr. Gambhir had “irresponsibly hoarded medicines” when people did not have access to them. “Though Mr. Gambhir’s intentions were in the right place, it is not allowed,” the court noted.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore